Apoptosis and acute brain ischemia in ischemic stroke
D Radak, N Katsiki, I Resanovic… - Current vascular …, 2017 - ingentaconnect.com
Apoptosis may contribute to a significant proportion of neuron death following acute brain
ischemia (ABI), but the underlying mechanisms are still not fully understood. Brain ischemia …
ischemia (ABI), but the underlying mechanisms are still not fully understood. Brain ischemia …
[HTML][HTML] Characterization and functional assessment of endothelial progenitor cells in ischemic stroke patients
M Kukumberg, AM Zaw, DHC Wong, CM Toh… - Stem cell reviews and …, 2021 - Springer
Endothelial dysfunction has been implicated in atherosclerosis, ischemic heart disease, and
stroke. Endothelial progenitor cells (EPCs), found in the bone marrow and peripheral blood …
stroke. Endothelial progenitor cells (EPCs), found in the bone marrow and peripheral blood …
[HTML][HTML] The prognostic value of serum cytokines in patients with acute ischemic stroke
The inflammatory response is an unavoidable process and contributes to the destruction of
cerebral tissue during the acute ischemic stroke (AIS) phase and has not been addressed …
cerebral tissue during the acute ischemic stroke (AIS) phase and has not been addressed …
[HTML][HTML] Estimation of stroke severity with National Institutes of Health Stroke Scale grading and retinal features: A cross-sectional study
Y Zhuo, Y Qu, J Wu, X Huang, W Yuan, J Lee, Z Yang… - Medicine, 2021 - journals.lww.com
Estimation of stroke severity with National Institutes of He... : Medicine Estimation of stroke
severity with National Institutes of Health Stroke Scale grading and retinal features: A cross-sectional …
severity with National Institutes of Health Stroke Scale grading and retinal features: A cross-sectional …
[HTML][HTML] Lasting impairments following transient ischemic attack and minor stroke: a systematic review protocol
B Hede Ebbesen, B Modrau, E Kontou, E Finch… - Frontiers in …, 2023 - frontiersin.org
Introduction The focus on medical management and secondary prevention following
Transient Ischemic Attack (TIA) and minor stroke is well-established. Evidence is emerging …
Transient Ischemic Attack (TIA) and minor stroke is well-established. Evidence is emerging …
[HTML][HTML] Safety and efficacy of the FRED Jr flow re-direction endoluminal device for intracranial aneurysms: retrospective multicenter experience with emphasis on …
J Jesser, ND Alberalar, O Kizilkilic, I Saatci… - Frontiers in …, 2021 - frontiersin.org
Background and Purpose: Flow diversion is increasingly used as an endovascular treatment
for intracranial aneurysms. In this retrospective multicenter study, we analyzed the safety …
for intracranial aneurysms. In this retrospective multicenter study, we analyzed the safety …
[HTML][HTML] Large Vessel Occlusion in Patients With Minor Ischemic Stroke in a Population-Based Study. The Dijon Stroke Registry
G Duloquin, V Crespy, P Jakubina, M Giroud… - Frontiers in …, 2022 - frontiersin.org
Introduction: Strategy for the acute management of minor ischemic stroke (IS) with large
vessel occlusion (LVO) is under debate, especially the benefits of mechanical …
vessel occlusion (LVO) is under debate, especially the benefits of mechanical …
[HTML][HTML] Intravenous tenecteplase compared with alteplase for minor ischaemic stroke: a secondary analysis of the AcT randomised clinical trial
Background In ischaemic stroke, minor deficits (National Institutes of Health Stroke Scale
(NIHSS)≤ 5) at presentation are common but often progress, leaving patients with …
(NIHSS)≤ 5) at presentation are common but often progress, leaving patients with …
The combination of CC chemokine receptor type 5 (CCR5) and Treg cells predicts prognosis in patients with ischemic stroke
J Zhang, G Liu, D Chen, Z Wang, D Chen, Y Liu… - Journal of …, 2020 - Elsevier
Abstract Objective Regulatory T cells (Tregs) play an important role in T cells. Csingle
bondC chemokine receptor 5 is a highly expressed chemokine receptor in T cells. They play …
bondC chemokine receptor 5 is a highly expressed chemokine receptor in T cells. They play …
Antiplatelet therapy after stroke: should it differ in the acute and chronic phase after stroke
Antiplatelet therapies should differ in the acute and chronic phases among patients with high-
risk stroke or TIA when more aggressive antiplatelet treatment is reasonable in the acute …
risk stroke or TIA when more aggressive antiplatelet treatment is reasonable in the acute …